DK109181A - Farmaceutiske salte af 4!-(9-acridinyl-amino) methansulfon-m-anisidid fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler - Google Patents

Farmaceutiske salte af 4!-(9-acridinyl-amino) methansulfon-m-anisidid fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler

Info

Publication number
DK109181A
DK109181A DK109181A DK109181A DK109181A DK 109181 A DK109181 A DK 109181A DK 109181 A DK109181 A DK 109181A DK 109181 A DK109181 A DK 109181A DK 109181 A DK109181 A DK 109181A
Authority
DK
Denmark
Prior art keywords
methansulphon
anisidide
acridinyl
medicines
procedures
Prior art date
Application number
DK109181A
Other languages
English (en)
Other versions
DK161072B (da
DK161072C (da
Inventor
J R Fisher
C P Kulier
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK109181A publication Critical patent/DK109181A/da
Publication of DK161072B publication Critical patent/DK161072B/da
Application granted granted Critical
Publication of DK161072C publication Critical patent/DK161072C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • C07H7/033Uronic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • C07H7/027Keto-aldonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK109181A 1980-03-11 1981-03-10 Analogifremgangsmaade til fremstilling af syreadditionssalte af 4'-(9-acridinylamino)methansulfon-m-anisidid DK161072C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12950380A 1980-03-11 1980-03-11
US12950380 1980-03-11

Publications (3)

Publication Number Publication Date
DK109181A true DK109181A (da) 1981-09-12
DK161072B DK161072B (da) 1991-05-27
DK161072C DK161072C (da) 1991-11-11

Family

ID=22440294

Family Applications (1)

Application Number Title Priority Date Filing Date
DK109181A DK161072C (da) 1980-03-11 1981-03-10 Analogifremgangsmaade til fremstilling af syreadditionssalte af 4'-(9-acridinylamino)methansulfon-m-anisidid

Country Status (16)

Country Link
EP (1) EP0035862B1 (da)
JP (1) JPS56142265A (da)
KR (1) KR840001561B1 (da)
AR (1) AR225346A1 (da)
AT (1) ATE7911T1 (da)
AU (1) AU535610B2 (da)
CA (1) CA1253160A (da)
DE (1) DE3164054D1 (da)
DK (1) DK161072C (da)
ES (1) ES500228A0 (da)
HU (1) HU183357B (da)
IE (1) IE50967B1 (da)
MX (1) MX6764E (da)
NZ (1) NZ196461A (da)
SU (1) SU1192619A3 (da)
ZA (1) ZA811304B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322424A (en) * 1980-01-24 1982-03-30 Bristol-Myers Company Crystalline glucoconate salt of m-AMSA and compositions containing same
ES512969A0 (es) * 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
DE3844518A1 (de) * 1988-03-23 1989-10-05 Karl Heinz Dr Med Thiel Verwendung von aminochinolinen und aminopyridinen zur iontophoretischen behandlung maligner tumore
EP3707127B1 (en) 2017-11-09 2025-12-31 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. COMPOUNDS FOR INHIBITING LY6K AND THEIR METHODS OF USE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1674923A (en) * 1924-04-12 1928-06-26 Schnorf Carl Process for the production of carbohydrate-acridine compounds and solutions thereof
AU534608B2 (en) * 1979-09-14 1984-02-09 Warner-Lambert Corporation Compounds having antitumour properties
JPS5687566A (en) * 1979-11-30 1981-07-16 Bristol Myers Co Anticancerous composition
ZA81420B (en) * 1980-01-24 1982-02-24 Bristol Myers Co Antitumor compositions

Also Published As

Publication number Publication date
HU183357B (en) 1984-04-28
CA1253160A (en) 1989-04-25
ATE7911T1 (de) 1984-06-15
NZ196461A (en) 1982-12-21
DK161072B (da) 1991-05-27
ES8202332A1 (es) 1982-01-16
EP0035862A2 (en) 1981-09-16
AR225346A1 (es) 1982-03-15
IE810396L (en) 1981-09-11
ZA811304B (en) 1982-06-30
AU535610B2 (en) 1984-03-29
ES500228A0 (es) 1982-01-16
JPH0343269B2 (da) 1991-07-01
DK161072C (da) 1991-11-11
AU6819281A (en) 1981-09-17
KR830005149A (ko) 1983-08-03
EP0035862B1 (en) 1984-06-13
DE3164054D1 (en) 1984-07-19
EP0035862A3 (en) 1981-11-18
MX6764E (es) 1986-06-30
SU1192619A3 (ru) 1985-11-15
IE50967B1 (en) 1986-08-20
JPS56142265A (en) 1981-11-06
KR840001561B1 (ko) 1984-10-05

Similar Documents

Publication Publication Date Title
DK146482A (da) Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK310383A (da) 14-fluormorphinaner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK164543C (da) Salte af l-carnitin og alkanoyl-l-carnitiner, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK410781A (da) N-arylbenzamid-derivater og salte deraf fremgangsmaade til deres fremstilling og deres anvendelse som herbicider
DK49283D0 (da) Pyrazoloxaziner, -thiaziner og - quinoliner, fremgangsmade til fremstilling deraf samt deres anvendelse som laegemidler
DK111387A (da) Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
DK519481A (da) Carboxylkylaminosyrederivater af substituerede proliner fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemidler
DK164917C (da) Analogifremgangsmaade til fremstilling af bicyklisk substituerede dipeptidderivater og deres farmaceutisk acceptable salte
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK398583D0 (da) Spergualin-beslaegtede forbindelser, fremgangsmader til fremstilling deraf samt deres anvendelse som laegemidler
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK160763C (da) Imidazooe1,5-aaapyridiner og salte deraf samt deres 5,6,7,8-tetrahydroderivater, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelse af forbindelserne
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK164323C (da) Salte af 5'-methylthio-5'-deoxyadenosin og langkaedede alkansulfonsyrer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne salte
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK166210C (da) Krystallinske cephalosporin-hydrohalogenidsalte, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK109181A (da) Farmaceutiske salte af 4!-(9-acridinyl-amino) methansulfon-m-anisidid fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK382283A (da) Thiazol-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK152491C (da) Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf
DK183886D0 (da) 4-phenylpropylindolderivater og deres salte og fremgangsmaade til deresfremstilling samt deres anvendelse som laegemidler
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK628086D0 (da) Pyrazinderivater og farmaceutisk acceptable salte heraf samt fremgangsmaade til fremstilling af og farmaceutisk komposition indeholdende samme
DK144784A (da) Optiske antipoder af 8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemiddel

Legal Events

Date Code Title Description
PUP Patent expired